Implementing a “One-Patch System” with On-Device Technology

Strategic partner Dong-A ST targets the domestic market

Application for KOSDAQ preliminary listing review in October… IPO planned for next year

A hidden powerhouse in digital healthcare, armed with strong on-device technology and a partnership with Dong-A ST, is preparing for its KOSDAQ debut. The company is Mezoo, developer of a mobile ambulatory remote patient monitoring (aRPM) solution.

A mobile remote patient monitoring solution is a system that transmits patients’ biosignals to a hospital monitoring center using patches attached to the body along with smartphones and other devices. It enables real-time delivery of biosignals such as electrocardiograms and respiration even when patients move inside or outside hospital wards or remain at home. This is currently one of the hottest areas in the domestic digital healthcare sector.

aRPM “Mezoo” Challenges Entry into KOSDAQ

Mezoo is a digital healthcare company co-founded in 2018 by CEO Jung-hwan Park, a graduate of Yonsei University’s Department of Biomedical Engineering, along with three biomedical engineering PhDs—Seong-pil Cho, Mi-hye Song, and Jae-yeon Shin.

The company’s core proprietary technologies include “biomedical telemetry,” which wirelessly and stably transmits biosignals such as ECG and respiration from patients and refines them into clinically usable data, and the “HCF framework,” which integrates overall hospital workflows. Based on these technologies, Mezoo has commercialized a mobile remote patient monitoring solution.

Mezoo’s solution enables 24-hour monitoring of an entire ward by linking data from a low-power, miniaturized patch-type electrocardiograph, HiCardi, attached to the patient’s chest, with smartphones, the cloud, and centralized monitoring software (LiveStudio).